Tekla Life Price To Earning vs. Shares Outstanding

HQL Stock  USD 13.84  0.14  1.00%   
Based on the measurements of profitability obtained from Tekla Life's financial statements, Tekla Life's profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Tekla Life's ability to earn profits and add value for shareholders. At this time, Tekla Life's EV To Sales is quite stable compared to the past year. Operating Cash Flow Sales Ratio is expected to grow at the current pace this year, although the value of Price To Sales Ratio will most likely fall to 16.39. At this time, Tekla Life's Operating Income is quite stable compared to the past year. Income Before Tax is expected to rise to about 89.6 M this year, although the value of Net Income From Continuing Ops will most likely fall to about 16 M.
For Tekla Life profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tekla Life to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tekla Life Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tekla Life's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tekla Life Sciences over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.425
Earnings Share
3.04
Revenue Per Share
0.134
Quarterly Revenue Growth
0.07
Return On Assets
(0)
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Tekla Life Sciences Shares Outstanding vs. Price To Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Tekla Life's current stock value. Our valuation model uses many indicators to compare Tekla Life value to that of its competitors to determine the firm's financial worth.
Tekla Life Sciences is rated # 4 in price to earning category among its peers. It is rated # 2 in shares outstanding category among its peers creating about  9,880,775  of Shares Outstanding per Price To Earning. The value of Common Stock Shares Outstanding is expected to slide to about 19.7 M. Comparative valuation analysis is a catch-all technique that is used if you cannot value Tekla Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Tekla Shares Outstanding vs. Price To Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Tekla Life

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
2.84 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Tekla Life

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
28.06 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Tekla Shares Outstanding Comparison

Tekla Life is currently under evaluation in shares outstanding category among its peers.

Tekla Life Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Tekla Life, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tekla Life will eventually generate negative long term returns. The profitability progress is the general direction of Tekla Life's change in net profit over the period of time. It can combine multiple indicators of Tekla Life, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income25.7 M27 M
Income Before Tax85.3 M89.6 M
Total Other Income Expense Net85.3 M89.6 M
Net Income25.7 M19.7 M
Net Income From Continuing Ops20.1 M16 M
Net Loss-94.1 M-89.4 M
Income Tax Expense25.7 M27 M
Interest Income184 K174.8 K
Net Interest Income235.1 K149.8 K
Change To Netincome-127.6 M-121.2 M
Net Income Per Share 0.71  0.76 
Net Income Per E B T 0.90  0.80 

Tekla Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Tekla Life. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tekla Life position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tekla Life's important profitability drivers and their relationship over time.

Use Tekla Life in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tekla Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Life will appreciate offsetting losses from the drop in the long position's value.

Tekla Life Pair Trading

Tekla Life Sciences Pair Trading Analysis

The ability to find closely correlated positions to Tekla Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tekla Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tekla Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tekla Life Sciences to buy it.
The correlation of Tekla Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tekla Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tekla Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tekla Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Tekla Life position

In addition to having Tekla Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run ISP Thematic Idea Now

ISP
ISP Theme
Internet Service Providers (ISP) companies and IT providers specializing in internet technologies. The ISP theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ISP Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Tekla Life Sciences is a strong investment it is important to analyze Tekla Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tekla Life's future performance. For an informed investment choice regarding Tekla Stock, refer to the following important reports:
Check out Risk vs Return Analysis.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
To fully project Tekla Life's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Tekla Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Tekla Life's income statement, its balance sheet, and the statement of cash flows.
Potential Tekla Life investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Tekla Life investors may work on each financial statement separately, they are all related. The changes in Tekla Life's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tekla Life's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.